PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 130 filers reported holding PROVENTION BIO INC in Q2 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,982,737 | +22.9% | 213,116 | -30.5% | 0.04% | +40.7% |
| Q4 2022 | $3,240,191 | +906.3% | 306,546 | +702.3% | 0.03% | +800.0% |
| Q2 2021 | $322,000 | -71.7% | 38,208 | -64.8% | 0.00% | -78.6% |
| Q1 2021 | $1,137,000 | +303.2% | 108,441 | +365.4% | 0.01% | +40.0% |
| Q2 2019 | $282,000 | – | 23,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |